UNH Stock Recent News
UNH LATEST HEADLINES
UnitedHealth Group beat Wall Street's Q1 revenue estimate. The healthcare giant posted a GAAP loss in Q1 because of a cyberattack on Change Healthcare.
Tesla (Nasdaq: TSLA) stock is off to a bumpy start in 2024, and it's still early in the year.
UnitedHealth Group's NYSE: UNH Q1 results were better than expected for two reasons: First, the stock price is now rebounding from long-term lows and deep value territory with ample upside ahead. Second, UnitedHealth analysts see it advancing more than 20% at the current consensus, and consensus may go higher because it's cautious.
The headline numbers for UnitedHealth (UNH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Shares of UnitedHealth Group Inc (NYSE:UNH) are surging today, after the blue-chip healthcare name's first-quarter results beat estimates, despite a cyberattack that is projected to cost the company up to $1.6 billion this year.
UnitedHealth Group (UNH) shares jumped over 7% in pre-market trading Tuesday after the company reported first-quarter results that surpassed analyst estimates, despite a cyberattack that disrupted some of its operations.
U.S. stock futures rose in premarket trading on Tuesday after better-than-expected earnings reports from corporate giants UnitedHealth Group and Bank of America.
UnitedHealth Group (UNH) came out with quarterly earnings of $6.91 per share, beating the Zacks Consensus Estimate of $6.63 per share. This compares to earnings of $6.26 per share a year ago.
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) shares got a pre-market shot in the arm as Tuesday's first-quarter earnings beat Wall Street expectations. The health insurance giant reported adjusted earnings per share of $6.91, which was better than the $6.59 EPS that analysts had forecast.
UnitedHealth Group, which churns out multi-billion-dollar profits every quarter from its diversified portfolio of health insurance and medical care services, reported a $1.4 billion quarterly loss on Tuesday due largely to the sale of its Brazilian business.